---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-002646"
form_type: "8-K"
ticker: "HSCS"
cik: "0001468492"
company_name: "HeartSciences Inc."
filed_at: "2023-02-13T23:59:59+00:00"
generated_at: "2026-06-19T15:53:07.670198+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Heart Test Labs gets Nasdaq extension until June 19, 2023 to regain equity compliance

## Summary
- Stockholders' equity was $1,082,676 as of Oct 31, 2022, below Nasdaq's $2.5M minimum for continued listing.
- Nasdaq granted extension to June 19, 2023 after company submitted a compliance plan.
- Company must file a public report describing the transaction/event that restores compliance.
- If not compliant by April 30, 2023 filing, Nasdaq may delist; company can appeal to a Hearings Panel.
- Warrants (HSCSW) also listed on Nasdaq and subject to same continued listing requirement.

## SEC filing metadata
- accession: 0000950170-23-002646
- form_type: 8-K
- ticker: HSCS
- cik: 0001468492
- company_name: HeartSciences Inc.
- filed_at: 2023-02-13T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1468492/000095017023002646/0000950170-23-002646-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1468492/000095017023002646/hscs-20230208.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-002646
- JSON: https://secwatch.observer/filing/0000950170-23-002646.json
- Plain text: https://secwatch.observer/filing/0000950170-23-002646.txt

## Key facts
- Listing & Compliance Notices
  HeartSciences Inc. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Deficiency: stockholders equity
  - Rules: 5550(b)(1)
  source text: February 8, 2023, the Company received a letter from Nasdaq in which it stated, that based on the Company's submission of its plan of compliance to Nasdaq, Nasdaq has determined to grant the Company an extension of time to regain compliance with Nasdaq Listing Rule 5550(b)(1) until June 19, 2023. The Company must furnish to the SEC and Nasdaq a publicly available report (e.g. a Form 8-K) which report, among other things, includes a description of the completed transaction or event that enabled the Company to satisfy the stockholders' equity requirement for continued listing. After filing the p
  evidence_url: https://www.sec.gov/Archives/edgar/data/1468492/000095017023002646/0000950170-23-002646-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.